Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/02/20
End: 09/30/21
Due: 09/30/22
Phase: N/A
Priority: Normal
Start: 04/01/23
End: 01/16/25
Due: 01/16/26
Phase: N/A
Priority: Normal
Start: 06/26/19
End: 05/31/23
Due: 05/31/24
Phase: N/A
Priority: Normal
Start: 12/04/17
End: 02/28/22
Due: 02/28/23
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Vielight RX Plus for the Treatment of COVID-19 Respiratory Symptoms | NCT04418505 | Vielight Inc. | user2@example.com | None | 2020-09-02 | 2021-09-30 | 2022-09-30 | - | - | 2025-07-14 |
| A Study Evaluating the Efficacy of the Vielight Neuro RX Gamma in the Treatment of Post COVID-19 Cognitive Impairment | NCT05857124 | Vielight Inc. | user2@example.com | None | 2023-04-01 | 2025-01-16 | 2026-01-16 | - | - | 2025-07-14 |
| Neuro RX Gamma - Pivotal Phase | NCT03484143 | Vielight Inc. | user2@example.com | None | 2019-06-26 | 2023-05-31 | 2024-05-31 | - | - | 2025-07-14 |
| Vielight Neuro RX Gamma - Feasibility Pilot | NCT03328195 | Vielight Inc. | user2@example.com | None | 2017-12-04 | 2022-02-28 | 2023-02-28 | - | - | 2025-07-14 |